CTXR · Citius Pharmaceuticals, Inc. · Suppliers & Customers
$0.55
-0.02 (-3.87%)
At close · Nov 4
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company estimates that its and Citius Oncology's collective available cash resources will be sufficient to fund our operations through November 2026. We will need to raise additional capital in the future to support our operations beyond November 2026, which raises substantial doubt about the Company's ability to continue as a going concern within one year after the date that the accompanying consolidated financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$15.13M
Shares
27.45M
Volume · Nov 4
138.62K
Avg daily vol (3M)
465.98K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Supply Chain
Customers, suppliers, competitors and partners, private companies included: the ones CTXR names, and the companies that name CTXR.
Read supply chains in your AI or your code through MCP and the API →
Pro
See who CTXR sells to, buys from and competes with
- 4 suppliers
- 0 customers
- 3 competitors
Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.